Nanologica AB Sustainability Reports
Nanologica AB develops, manufactures, and sells advanced silica-based chromatography materials and consumables used by pharmaceutical manufacturers for the purification of peptide drugs such as insulin and GLP-1 analogues.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 54930017L41C7P87LP22
FIGI: BBG009YXXXT0
7 reports from 2020 to 2025
